Palisade Bio (PALI) Intangibles (2010 - 2021)
Palisade Bio (PALI) posted quarterly Intangibles of $141642.0 for Q1 2021, down 78.2% year-over-year from $649745.0 in Q1 2020, and down 3.73% quarter-over-quarter from $147133.0 in Q4 2020.
Powered by 
Analysis
Palisade Bio (PALI) Intangibles (2010 - 2021) Analysis & Trends
Palisade Bio (PALI) has reported Intangibles for 12 consecutive years, with $141642.0 the latest figure, recorded in Q1 2021.
- In Q1 2021, Intangibles fell 78.2% year-over-year to $141642.0; the TTM figure through Mar 2021 stood at $141642.0 (down 78.2% YoY), while the FY2020 annual figure was $147133.0, down 78.0% from the prior year.
- Intangibles retreated to $141642.0 in Q1 2021 per PALI's latest filing, from $147133.0 in the prior quarter.
- Across five years, Intangibles topped out at $945066.0 in Q2 2017 and bottomed at $141642.0 in Q1 2021.
- Historically, Intangibles has averaged $669691.8 across 5 years, with a median of $738404.0 in 2019.
- Annual changes were most pronounced in 2017 — Intangibles decreased 6.98% — and 2021, when it tumbled 78.2%.
- Palisade Bio's Intangibles stood at $883462.0 in 2017, then declined by 13.57% to $763543.0 in 2018, then retreated by 12.39% to $668936.0 in 2019, then slumped by 78.0% to $147133.0 in 2020, then retreated by 3.73% to $141642.0 in 2021.
- Business Quant data shows PALI's Intangibles at $141642.0 in Q1 2021, $147133.0 in Q4 2020, and $152625.0 in Q3 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 266.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 63.28 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 60.96 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 93.49 Mn |
| 10 | Palisade Bio | 440.73 Mn | 315.53 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2021 | 141,642.00 |
| Dec 31, 2020 | 147,133.00 |
| Sep 30, 2020 | 152,625.00 |
| Jun 30, 2020 | 630,554.00 |
| Mar 31, 2020 | 649,745.00 |
| Dec 31, 2019 | 668,936.00 |
| Sep 30, 2019 | 688,127.00 |
| Jun 30, 2019 | 713,265.00 |
| Mar 31, 2019 | 738,404.00 |
| Dec 31, 2018 | 763,543.00 |
| Sep 30, 2018 | 788,733.00 |
| Jun 30, 2018 | 814,023.00 |
| Mar 31, 2018 | 839,314.00 |
| Dec 31, 2017 | 883,462.00 |
| Sep 30, 2017 | 915,457.00 |
| Jun 30, 2017 | 945,066.00 |
| Mar 31, 2017 | 904,732.00 |
| Dec 31, 2016 | 990,153.00 |
| Sep 30, 2016 | 984,125.00 |
| Jun 30, 2016 | 1.03 Mn |